BI-248.610

Study Sponsor: Boehringer Ingelheim

Study Title

A 12-week Study of Pramipexole ER in Patients With Parkinson's Disease, Followed by a 52-week Long-term Treatment Period

Medicine or Vaccine (generic name)

pramipexole

Sponsor Identification Number

248.610

Trial Registry Identification Number(#'s)

NCT00560508

Medical Condition

Parkinson Disease

Phase

Phase 2

Link to study details on the BI Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

April 2014